Brooks Laboratories Ltd — Quarterly Results & Earnings

₹37.11

-7.63%

Profit Growth YoY301.52%Latest quarter

Sales Growth YoY12.79%Latest quarter

Sales CAGR 5YN/A5 year compound

Profit CAGR 5YN/A5 year compound

📋

Quarterly Performance

YoY Profit Growth+301.52%

🔥 Exceptional growth

YoY Sales Growth+12.79%

✅ Strong growth

OPM 5Y Average

Operating profit margin

-17.61%

EPS Growth 5Y

N/A

Interest Coverage

Higher = safer debt servicing

13.63

ROE

-12.21%

ROCE

-9.93%

💡

Growth Analysis

Brooks Laboratories Ltd reported YoY profit growth of 301.52% and revenue growth of 12.79% in the latest quarter. Double-digit profit growth above 20% is exceptional — indicates strong business momentum. Over 5 years, sales compounded at N/A and profits at N/A annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on Brooks Laboratories Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.